Biological heterogeneity in ADRD

ADRD 的生物异质性

基本信息

  • 批准号:
    10433865
  • 负责人:
  • 金额:
    $ 293.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-01 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Abstract The UW ADRC's driving scientific focus is investigating the biological heterogeneity of ADRD – the mechanistic and biological underpinnings of the pathophysiology of disease as well as the factors countering degeneration and dementia. Our Center was one of the first to recognize etiologic heterogeneity in Alzheimer's disease2 and this focus is still urgently needed. New technologies and paradigms have emerged to analyze biological mechanisms of ADRD, and require well characterized human subjects and well-curated biospecimens. The proposed organizing framework for our core research resources is multi-disciplinary ADRD phenotyping. The four key disciplines to integrate are genetic, cognitive, topographic/anatomic, and neuropathologic. In this framework, the brain space is the point of integration of the other biomarkers of AD, as the magnitude and location of the different pathologies are the most tangible and objective manifestation of the outcome of different pathophysiological pathways. Thus a key aspect of our work will include integrating biomarkers extended over the cerebral cortex, as derived from imaging and neuropathology, with fluid biomarkers, cognitive and genetic information. An important goal is to support better stratification of AD phenotypes to advance investigation of candidate AD mechanisms. The UW ADRC is uniquely poised to undertake this work, which incorporates the historical strengths of the Center and research resources of the UW, leverages the collective expertise of the Core Leads and the Director, and benefits from new technical abilities that enable us to implement this program. New components are being proposed to bring expertise dedicated to bridging disciplines by innovations in techniques, methods, and informatics. These include Stem Cell and Precision -omics components in the Precision Neuropathology Core, Psychometrics component in the Clinical Core, Informatics expertise in the new Imaging and Biomarker Core and an Open Neuroscience workshop in the Research Education Component. Our Center's philosophy is to view ADRD not only through the lens of what is lost, but also through what is spared, and the associated retained strengths. This perspective permeates our Center, from motivating our interest in the biological and mechanistic basis of resilience and anatomic sparing, to the outreach efforts of the ADRC and its associated Memory and Brain Wellness Center. Another important theme of our Center is ADRD in American Indians and Alaska Natives. Building on our successful efforts in the last 5 years, we plan to extend our outreach efforts to Native tribes and organizations in Washington State, to improve their readiness for ADRD research, and to make a focused effort to understand and develop models to overcome the barriers to biospecimen collection and data sharing in this population.
抽象的 华盛顿大学 ADRC 的科学重点是研究 ADRD 的生物异质性 - 机制 疾病病理生理学的生物学基础以及对抗退化的因素 和痴呆症。我们的中心是最早认识到阿尔茨海默病病因异质性的中心之一2 仍然迫切需要这一重点。分析生物的新技术和范式已经出现 ADRD 的机制,需要明确特征的人类受试者和精心策划的生物样本。 我们的核心研究资源拟议的组织框架是多学科 ADRD 表型分析。需要整合的四个关键学科是遗传学、认知学、地形/解剖学和 神经病理学。在这个框架中,大脑空间是 AD 其他生物标志物的整合点,如 不同病变的严重程度和部位是疾病最具体、最客观的表现。 不同病理生理途径的结果。因此,我们工作的一个关键方面将包括整合 来自成像和神经病理学的生物标志物延伸到大脑皮层,其中有液体 生物标志物、认知和遗传信息。一个重要目标是支持 AD 更好的分层 表型以推进候选 AD 机制的研究。 华盛顿大学 ADRC 已准备好承担这项工作,该工作融合了以下领域的历史优势: 华盛顿大学的中心和研究资源,利用核心领导者和 总监,并受益于使我们能够实施该计划的新技术能力。新组件 正在提议通过技术、方法的创新来带来致力于桥接学科的专业知识, 和信息学。其中包括精准神经病理学中的干细胞和精准组学成分 临床核心中的核心、心理测量学组成部分、新成像和生物标记中的信息学专业知识 研究教育部分的核心和开放神经科学研讨会。 我们中心的理念是不仅通过失去的东西来看待ADRD,而且通过 哪些是幸免的,以及相关的保留优势。这种观点渗透到我们的中心,从激励 我们对恢复力和解剖学保护的生物学和机械基础的兴趣,以及外展工作 ADRC 及其相关的记忆和大脑健康中心。 我们中心的另一个重要主题是美洲印第安人和阿拉斯加原住民的 ADRD。建立在 鉴于我们过去 5 年的成功努力,我们计划将我们的外展工作扩展到原住民部落和 华盛顿州的组织,以提高他们对 ADRD 研究的准备程度,并制定有针对性的 努力理解和开发模型以克服生物样本收集和数据共享的障碍 在这个人群中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas J. Grabowski其他文献

A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease
  • DOI:
    10.1007/s40263-024-01097-w
  • 发表时间:
    2024-06-05
  • 期刊:
  • 影响因子:
    7.400
  • 作者:
    Michael H. Rosenbloom;Tricia O’Donohue;Domi Zhou-Clark;Deepashni Mala;Andrew Frazier;Michael Tarrant;Michelle Modrijan;Melora Riveira;Darla Chapman;Yvonne Griffin;Lauren Shakalis;Thomas J. Grabowski
  • 通讯作者:
    Thomas J. Grabowski
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer’s disease
  • DOI:
    10.1186/s13059-025-03564-z
  • 发表时间:
    2025-07-17
  • 期刊:
  • 影响因子:
    9.400
  • 作者:
    Farid Rajabli;Penelope Benchek;Giuseppe Tosto;Nicholas Kushch;Jin Sha;Katrina Bazemore;Congcong Zhu;Wan-Ping Lee;Jacob Haut;Kara L. Hamilton-Nelson;Nicholas R. Wheeler;Yi Zhao;John J. Farrell;Michelle A. Grunin;Yuk Yee Leung;Pavel P. Kuksa;Donghe Li;Eder Lucio da Fonseca;Jesse B. Mez;Ellen L. Palmer;Jagan Pillai;Richard M. Sherva;Yeunjoo E. Song;Xiaoling Zhang;Takeshi Ikeuchi;Taha Iqbal;Omkar Pathak;Otto Valladares;Dolly Reyes-Dumeyer;Amanda B. Kuzma;Erin Abner;Larry D. Adams;Perrie M. Adams;Alyssa Aguirre;Marilyn S. Albert;Roger L. Albin;Mariet Allen;Lisa Alvarez;Liana G. Apostolova;Steven E. Arnold;Sanjay Asthana;Craig S. Atwood;Sanford Auerbach;Gayle Ayres;Clinton T. Baldwin;Robert C. Barber;Lisa L. Barnes;Sandra Barral;Thomas G. Beach;James T. Becker;Gary W. Beecham;Duane Beekly;Bruno A. Benitez;David Bennett;John Bertelson;Thomas D. Bird;Deborah Blacker;Bradley F. Boeve;James D. Bowen;Adam Boxer;James Brewer;James R. Burke;Jeffrey M. Burns;Joseph D. Buxbaum;Nigel J. Cairns;Laura B. Cantwell;Chuanhai Cao;Christopher S. Carlson;Cynthia M. Carlsson;Regina M. Carney;Minerva M. Carrasquillo;Scott Chasse;Marie-Francoise Chesselet;Nathaniel A. Chin;Helena C. Chui;Jaeyoon Chung;Suzanne Craft;Paul K. Crane;David H. Cribbs;Elizabeth A. Crocco;Carlos Cruchaga;Michael L. Cuccaro;Munro Cullum;Eveleen Darby;Barbara Davis;Philip L. De Jager;Charles DeCarli;John DeToledo;Malcolm Dick;Dennis W. Dickson;Beth A. Dombroski;Rachelle S. Doody;Ranjan Duara;NIlüfer Ertekin-Taner;Denis A. Evans;Kelley M. Faber;Thomas J. Fairchild;Kenneth B. Fallon;David W. Fardo;Martin R. Farlow;Victoria Fernandez-Hernandez;Steven Ferris;Robert P. Friedland;Tatiana M. Foroud;Matthew P. Frosch;Brian Fulton-Howard;Douglas R. Galasko;Adriana Gamboa;Marla Gearing;Daniel H. Geschwind;Bernardino Ghetti;John R. Gilbert;Rodney C.P. Go;Alison M. Goate;Thomas J. Grabowski;Neill R. Graff-Radford;Robert C. Green;John H. Growdon;Hakon Hakonarson;James Hall;Ronald L. Hamilton;Oscar Harari;John Hardy;Lindy E. Harrell;Elizabeth Head;Victor W. Henderson;Michelle Hernandez;Timothy Hohman;Lawrence S. Honig;Ryan M. Huebinger;Matthew J. Huentelman;Christine M. Hulette;Bradley T. Hyman;Linda S. Hynan;Laura Ibanez;Gail P. Jarvik;Suman Jayadev;Lee-Way Jin;Kim Johnson;Leigh Johnson;M. Ilyas Kamboh;Anna M. Karydas;Mindy J. Katz;John S. Kauwe;Jeffrey A. Kaye;C. Dirk Keene;Aisha Khaleeq;Masataka Kikuchi;Ronald Kim;Janice Knebl;Neil W. Kowall;Joel H. Kramer;Walter A. Kukull;Frank M. LaFerla;James J. Lah;Eric B. Larson;Alan Lerner;James B. Leverenz;Allan I. Levey;Andrew P. Lieberman;Richard B. Lipton;Mark Logue;Oscar L. Lopez;Kathryn L. Lunetta;Constantine G. Lyketsos;Douglas Mains;Flanagan E. Margaret;Daniel C. Marson;Eden RR. Martin;Frank Martiniuk;Deborah C. Mash;Eliezer Masliah;Paul Massman;Arjun Masurkar;Wayne C. McCormick;Susan M. McCurry;Andrew N. McDavid;Stefan McDonough;Ann C. McKee;Marsel Mesulam;Bruce L. Miller;Carol A. Miller;Joshua W. Miller;Thomas J. Montine;Edwin S. Monuki;John C. Morris;Shubhabrata Mukherjee;Amanda J. Myers;Trung Nguyen;Thomas Obisesan;Sid O’Bryant;John M. Olichney;Marcia Ory;Raymond Palmer;Joseph E. Parisi;Henry L. Paulson;Valory Pavlik;David Paydarfar;Victoria Perez;Elaine Peskind;Ronald C. Petersen;Helen Petrovitch;Aimee Pierce;Marsha Polk;Wayne W. Poon;Huntington Potter;Liming Qu;Mary Quiceno;Joseph F. Quinn;Ashok Raj;Murray Raskind;Eric M. Reiman;Barry Reisberg;Joan S. Reisch;John M. Ringman;Erik D. Roberson;Monica Rodriguear;Ekaterina Rogaeva;Howard J. Rosen;Roger N. Rosenberg;Donald R. Royall;Marwan Sabbagh;A. Dessa Sadovnick;Mark A. Sager;Mary Sano;Andrew J. Saykin;Julie A. Schneider;Lon S. Schneider;William W. Seeley;Susan H. Slifer;Scott Small;Amanda G. Smith;Janet P. Smith;Joshua A. Sonnen;Salvatore Spina;Peter St George-Hyslop;Takiyah D. Starks;Robert A. Stern;Alan B. Stevens;Stephen M. Strittmatter;David Sultzer;Russell H. Swerdlow;Rudolph E. Tanzi;Jeffrey L. Tilson;John Q. Trojanowski;Juan C. Troncoso;Magda Tsolaki;Debby W. Tsuang;Vivianna M. Van Deerlin;Linda J. van Eldik;Jeffery M. Vance;Badri N. Vardarajan;Robert Vassar;Harry V. Vinters;Jean-Paul Vonsattel;Sandra Weintraub;Kathleen A. Welsh-Bohmer;Patrice L. Whitehead;Ellen M. Wijsman;Kirk C. Wilhelmsen;Benjamin Williams;Jennifer Williamson;Henrik Wilms;Thomas S. Wingo;Thomas Wisniewski;Randall L. Woltjer;Martin Woon;Clinton B. Wright;Chuang-Kuo Wu;Steven G. Younkin;Chang-En Yu;Lei Yu;Xiongwei Zhu;Brian W. Kunkle;William S. Bush;Akinori Miyashita;Goldie S. Byrd;Li-San Wang;Lindsay A. Farrer;Jonathan L. Haines;Richard Mayeux;Margaret A. Pericak-Vance;Gerard D. Schellenberg;Gyungah R. Jun;Christiane Reitz;Adam C. Naj
  • 通讯作者:
    Adam C. Naj

Thomas J. Grabowski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas J. Grabowski', 18)}}的其他基金

Biological heterogeneity in ADRD
ADRD 的生物异质性
  • 批准号:
    10171541
  • 财政年份:
    2020
  • 资助金额:
    $ 293.35万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10433866
  • 财政年份:
    2020
  • 资助金额:
    $ 293.35万
  • 项目类别:
Imaging and Biomarker Core
成像和生物标志物核心
  • 批准号:
    9921709
  • 财政年份:
    2020
  • 资助金额:
    $ 293.35万
  • 项目类别:
Biological heterogeneity in ADRD
ADRD 的生物异质性
  • 批准号:
    10654484
  • 财政年份:
    2020
  • 资助金额:
    $ 293.35万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10684456
  • 财政年份:
    2020
  • 资助金额:
    $ 293.35万
  • 项目类别:
Imaging and Biomarker Core
成像和生物标志物核心
  • 批准号:
    10661547
  • 财政年份:
    2020
  • 资助金额:
    $ 293.35万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10661522
  • 财政年份:
    2020
  • 资助金额:
    $ 293.35万
  • 项目类别:
Biological heterogeneity in ADRD
ADRD 的生物异质性
  • 批准号:
    9921703
  • 财政年份:
    2020
  • 资助金额:
    $ 293.35万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10171542
  • 财政年份:
    2020
  • 资助金额:
    $ 293.35万
  • 项目类别:
Imaging and Biomarker Core
成像和生物标志物核心
  • 批准号:
    10433872
  • 财政年份:
    2020
  • 资助金额:
    $ 293.35万
  • 项目类别:

相似海外基金

NNA Research: Collaborative Research: Towards resilient water infrastructure in Alaska Native communities through knowledge co-production
NNA 研究:合作研究:通过知识共同生产为阿拉斯加原住民社区打造具有复原力的水基础设施
  • 批准号:
    2220518
  • 财政年份:
    2023
  • 资助金额:
    $ 293.35万
  • 项目类别:
    Standard Grant
NNA Research: Collaborative Research: Towards resilient water infrastructure in Alaska Native communities through knowledge co-production
NNA 研究:合作研究:通过知识共同生产为阿拉斯加原住民社区打造具有复原力的水基础设施
  • 批准号:
    2220516
  • 财政年份:
    2023
  • 资助金额:
    $ 293.35万
  • 项目类别:
    Standard Grant
NNA Research: Collaborative Research: Towards resilient water infrastructure in Alaska Native communities through knowledge co-production
NNA 研究:合作研究:通过知识共同生产为阿拉斯加原住民社区打造具有复原力的水基础设施
  • 批准号:
    2220517
  • 财政年份:
    2023
  • 资助金额:
    $ 293.35万
  • 项目类别:
    Standard Grant
Deep molecular and cellular profiling of colorectal cancer tumor and immune microenvironment in Alaska Native people
阿拉斯加原住民结直肠癌肿瘤和免疫微环境的深入分子和细胞分析
  • 批准号:
    10651205
  • 财政年份:
    2023
  • 资助金额:
    $ 293.35万
  • 项目类别:
Development of an Instrument for Assessment of Indigenous Historical Trauma as a Social Determinant of Health Among American Indian/Alaska Native Populations
开发一种评估土著历史创伤作为美洲印第安人/阿拉斯加原住民健康社会决定因素的工具
  • 批准号:
    10736011
  • 财政年份:
    2023
  • 资助金额:
    $ 293.35万
  • 项目类别:
Understanding cancer and comorbidities among American Indian and Alaska Native people
了解美洲印第安人和阿拉斯加原住民的癌症和合并症
  • 批准号:
    10722119
  • 财政年份:
    2023
  • 资助金额:
    $ 293.35万
  • 项目类别:
Urban American Indian/Alaska Native Cultural Eating Values and Behaviors: Community-based, mixed methods research to inform a holistic and culturally-informed diabetes prevention intervention program
城市美洲印第安人/阿拉斯加原住民文化饮食价值观和行为:基于社区的混合方法研究,为全面且文化丰富的糖尿病预防干预计划提供信息
  • 批准号:
    10679529
  • 财政年份:
    2023
  • 资助金额:
    $ 293.35万
  • 项目类别:
Planning Grant: Moving Forward Together - Transforming Arctic Geosciences for Alaska Native Sovereignty and Science
规划拨款:共同前进 - 为阿拉斯加原住民主权和科学转变北极地球科学
  • 批准号:
    2228064
  • 财政年份:
    2023
  • 资助金额:
    $ 293.35万
  • 项目类别:
    Standard Grant
Alaska Native Communities Advancing Vaccine Uptake
阿拉斯加原住民社区促进疫苗接种
  • 批准号:
    10504537
  • 财政年份:
    2022
  • 资助金额:
    $ 293.35万
  • 项目类别:
Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation: an RCT
基于阿拉斯加原住民家庭的戒烟经济激励干预措施:随机对照试验
  • 批准号:
    10612408
  • 财政年份:
    2022
  • 资助金额:
    $ 293.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了